| 161.98 Data as of 12:58pm ET |  -2.38 / -1.45%Today’s Change | 130.54 Today|||52-Week Range 194.44 | -0.75% Year-to-Date |
| World's Largest Chemical Company Makes a Splash in Enzymes 9:51am / MotleyFool.com | Encouraging Data from Novartis - Analyst Blog May 29 / Zacks.com |
| Novo Nordisk A/S (NVO): Today's Featured Drugs Winner Jun 04 / TheStreet.com | Encouraging Data from Novartis - Analyst Blog May 29 / Zacks.com |
| Drugs Stocks On The Rise With Help From 3 Stocks Jun 04 / TheStreet.com | Obesity Data on Novo Nordisk's Victoza - Analyst Blog May 28 / Zacks.com |
| Novo Nordisk Seeks IDegLira Approval - Analyst Blog Jun 03 / Zacks.com |
| Previous close | 164.36 |
| Today’s open | 162.24 |
| Day’s range | 161.82 - 163.14 |
| Volume | 96,084 |
| Average volume (3 months) | 277,482 |
| Market cap | $71.0B |
| Dividend yield | 1.97% |
| Earnings growth (last year) | +19.33% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +13.80% |
| Revenue growth (last year) | +8.57% |
| P/E ratio | -- |
| Price/Sales | 6.61 |
| Price/Book | 12.42 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie Inc | +0.19 | +0.44% |
| BMYBristol-Myers Squibb... | +0.01 | +0.02% |
| AZNAstraZeneca PLC | -0.10 | -0.19% |
| LLYEli Lilly and Co | +0.50 | +0.96% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $2.11 |
| Annual revenue (last year) | $13.5B |
| Annual profit (last year) | $3.7B |
| Net profit margin | 27.47% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
President & Chief Executive Officer Lars Rebien Sørensen |
Chief Operating Officer & Executive Vice President Kåre Schultz |
Corporate headquarters Bagsværd, -- |
.
